Pullen appointed to board of Phylogica
You have no credits left. To view this article subscribe to Business News.
You have used {{points}} and have {{current_points}} remaining. Your credits will reset on {{reset_date}}.
This article is part of a special report and is available to paid Business News subscribers only.
You can purchase access to this special report or subscribe to Business News.
You can purchase access to this special report or subscribe to Business News.
This article is premium content and is available to paid Business News subscribers only.
Subscribe to Business News.
Subscribe to Business News.
Tuesday, 19 April, 2005 - 22:00
Recently-listed lead drug developer, Phylogica has announced the appointment of Greg Pullen as a non-executive director.
Dr Pullen recently headed the licensing and company start-up group at Auckland UniServices Ltd, the commercialisation entity of the University of Auckland.
Before joining UniServices, he held senior executive positions in the Australian biotech and pharmaceutical sector.